BG104451A - Antiestrogen and progestin-containing peroral contraceptives - Google Patents

Antiestrogen and progestin-containing peroral contraceptives

Info

Publication number: BG104451A
Authority: BG; Bulgaria
Prior art keywords: antiestrogen; progestin; peroral; contraceptives; neuterotrophic
Prior art date: 1997-11-06

Application number

BG104451A

Other languages

Bulgarian (bg)

English (en)

Inventor

Michael Gast

Christopher Miller

Original Assignee

Wyeth

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-06

Filing date

2000-05-17

Publication date

2000-12-29

2000-05-17 Application filed by Wyeth filed Critical Wyeth

2000-12-29 Publication of BG104451A publication Critical patent/BG104451A/xx

Links

RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title abstract 2
229940046836 anti-estrogen Drugs 0.000 title abstract 2
230000001833 anti-estrogenic effect Effects 0.000 title abstract 2
239000000328 estrogen antagonist Substances 0.000 title abstract 2
239000000583 progesterone congener Substances 0.000 title abstract 2
229940124558 contraceptive agent Drugs 0.000 title 1
239000003433 contraceptive agent Substances 0.000 title 1
230000027758 ovulation cycle Effects 0.000 abstract 1
230000001850 reproductive effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BG104451A 1997-11-06 2000-05-17 Antiestrogen and progestin-containing peroral contraceptives BG104451A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US96508397A	1997-11-06	1997-11-06
PCT/US1998/023427 WO1999024027A2 (en)	1997-11-06	1998-11-04	Anti-estrogen plus progestin containing oral contraceptives

Publications (1)

Publication Number	Publication Date
BG104451A true BG104451A (en)	2000-12-29

Family

ID=25509417

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104451A BG104451A (en)	1997-11-06	2000-05-17	Antiestrogen and progestin-containing peroral contraceptives

Country Status (28)

Country	Link
EP (1)	EP1051179B1 (cs)
JP (1)	JP2001522798A (cs)
CN (1)	CN1278732A (cs)
AR (1)	AR016667A1 (cs)
AT (1)	ATE304359T1 (cs)
AU (2)	AU760540B2 (cs)
BG (1)	BG104451A (cs)
BR (1)	BR9813982A (cs)
CA (1)	CA2307210A1 (cs)
CZ (1)	CZ294155B6 (cs)
DE (1)	DE69831605T2 (cs)
DK (1)	DK1051179T3 (cs)
EA (1)	EA200000492A1 (cs)
EE (1)	EE04092B1 (cs)
ES (1)	ES2246541T3 (cs)
GE (1)	GEP20043290B (cs)
HR (1)	HRP20000269A2 (cs)
HU (1)	HUP0100293A3 (cs)
ID (1)	ID24568A (cs)
IL (1)	IL135621A0 (cs)
NO (1)	NO20002167L (cs)
NZ (1)	NZ503890A (cs)
PL (1)	PL340623A1 (cs)
SK (1)	SK6482000A3 (cs)
TR (1)	TR200001268T2 (cs)
UA (1)	UA68365C2 (cs)
WO (1)	WO1999024027A2 (cs)
ZA (1)	ZA9810136B (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL120263A0 (en) *	1996-02-28	1997-06-10	Pfizer	Combination therapy to prevent bone loss-progesterone and estrogen agonists
AU760378B2 (en) *	1998-05-15	2003-05-15	Wyeth Llc	2-phenyl-1-(4-(2-aminoethoxy)-benzyl)-indole in combination with estrogens
US6479535B1 (en)	1998-05-15	2002-11-12	Wyeth	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6380166B1 (en)	1999-09-13	2002-04-30	American Home Products Corporation	Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
MXPA02002654A (es) *	1999-09-13	2002-07-30	Wyeth Corp	Glucopiranosidos conjugados de 2-(4-hidroxi -fenil)-1- [4-(2-amin- 1-il-etoxi) -bencil] -1h -indol -5- oles.
US6376486B1 (en)	2000-07-06	2002-04-23	American Home Products Corporation	Methods of inhibiting sphincter incontinence
WO2003011282A1 (en)	2001-07-31	2003-02-13	Pfizer Products Inc.	Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
WO2006049889A1 (en) *	2004-10-27	2006-05-11	Janssen Pharmaceutica N.V.	Indole derivatives useful as progesterone receptor modulators
FR2880625B1 (fr) *	2005-01-07	2007-03-09	Sanofi Aventis Sa	Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) *	2005-05-13	2006-12-29	Schering Ag	Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) *	2008-11-11	2010-05-12	Bayer Schering Pharma Aktiengesellschaft	Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
KR101698238B1 (ko)	2010-06-10	2017-01-19	세라곤 파마슈티컬스, 인크.	에스트로겐 수용체 조정제 및 이의 용도
US9187460B2 (en)	2011-12-14	2015-11-17	Seragon Pharmaceuticals, Inc.	Estrogen receptor modulators and uses thereof
KR20240142622A (ko)	2015-10-01	2024-09-30	올레마 파마슈티컬스 인코포레이티드	테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
PT3386500T (pt)	2015-12-09	2023-01-06	Univ Illinois	Supressores seletivos do recetor de estrogénio à base de benzotiofeno
EP3454856B1 (en)	2016-05-10	2024-09-11	C4 Therapeutics, Inc.	Heterocyclic degronimers for target protein degradation
CN109790143A (zh)	2016-05-10	2019-05-21	C4医药公司	用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
CN109641874A (zh)	2016-05-10	2019-04-16	C4医药公司	用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
CN120887906A (zh)	2016-05-10	2025-11-04	C4医药公司	用于靶蛋白降解的螺环降解决定子体
JP2019520379A (ja)	2016-07-01	2019-07-18	ジー１セラピューティクス，インコーポレイテッド	ピリミジン系の抗増殖剤
WO2018081168A2 (en)	2016-10-24	2018-05-03	The Board Of Trustees Of The University Of Illinois	Benzothiophene-based selective mixed estrogen receptor downregulators
CA3048057A1 (en)	2017-01-06	2018-07-12	G1 Therapeutics, Inc.	Combination therapy for the treatment of cancer
AU2018217809A1 (en)	2017-02-10	2019-08-22	G1 Therapeutics, Inc.	Benzothiophene estrogen receptor modulators
WO2018237026A1 (en)	2017-06-20	2018-12-27	C4 Therapeutics, Inc.	N / O-LINKED DEGRONS AND DEGRONIMERS FOR DEGRADATION OF PROTEINS
ES2988261T3 (es)	2017-06-29	2024-11-19	G1 Therapeutics Inc	Formas mórficas de GIT38 y métodos de fabricación de las mismas
WO2020132561A1 (en)	2018-12-20	2020-06-25	C4 Therapeutics, Inc.	Targeted protein degradation
AU2020311337B2 (en)	2019-07-07	2026-02-26	Olema Pharmaceuticals, Inc.	Regimens of estrogen receptor antagonists
PH12022550950A1 (en)	2019-12-20	2023-07-03	C4 Therapeutics Inc	Isoindolinone and indazole compounds for the degradation of egfr
JP7746278B2 (ja)	2020-03-05	2025-09-30	シーフォーセラピューティクス，インコーポレイテッド	Ｂｒｄ９の標的分解のための化合物
JP2023538517A (ja)	2020-08-05	2023-09-08	シーフォーセラピューティクス，インコーポレイテッド	Ｒｅｔの標的分解のための化合物
EP4351583A4 (en)	2021-06-08	2025-06-04	C4 Therapeutics, Inc.	THERAPEUTICS TO DEGRADE MUTANT BRAF
CN119998285A (zh)	2022-08-03	2025-05-13	百时美施贵宝公司	用于调控ret蛋白的化合物
CN120530116A (zh)	2022-11-04	2025-08-22	百时美施贵宝公司	Ret-ldd蛋白抑制剂
KR20250117789A (ko)	2022-11-04	2025-08-05	브리스톨-마이어스 스큅 컴퍼니	Ret-ldd 단백질 분해제
AU2024310341A1 (en)	2023-06-30	2026-02-12	Merck Patent Gmbh	Heterobifunctional compounds for the degradation of kras protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA716118B (en) *	1970-10-05	1972-05-31	Richardson Merrell Inc	Contraception
ZA9510926B (en) *	1994-12-23	1996-07-03	Schering Ag	Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120266A (en) *	1996-02-28	2005-05-17	Pfizer	Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
IL120263A0 (en) *	1996-02-28	1997-06-10	Pfizer	Combination therapy to prevent bone loss-progesterone and estrogen agonists
DK0802183T3 (da) *	1996-04-19	2002-02-04	American Home Prod	Østrogenforbindelser
US5747480A (en) *	1996-05-08	1998-05-05	American Home Products Corporation	Oral contraceptive

1998
- 1998-04-11 UA UA2000063196A patent/UA68365C2/uk unknown
- 1998-04-11 ID IDW20000811A patent/ID24568A/id unknown
- 1998-11-04 AT AT98956525T patent/ATE304359T1/de not_active IP Right Cessation
- 1998-11-04 DE DE69831605T patent/DE69831605T2/de not_active Expired - Lifetime
- 1998-11-04 HU HU0100293A patent/HUP0100293A3/hu unknown
- 1998-11-04 IL IL13562198A patent/IL135621A0/xx unknown
- 1998-11-04 BR BR9813982-7A patent/BR9813982A/pt not_active Application Discontinuation
- 1998-11-04 EP EP98956525A patent/EP1051179B1/en not_active Expired - Lifetime
- 1998-11-04 GE GEAP19985364A patent/GEP20043290B/en unknown
- 1998-11-04 SK SK648-2000A patent/SK6482000A3/sk unknown
- 1998-11-04 DK DK98956525T patent/DK1051179T3/da active
- 1998-11-04 PL PL98340623A patent/PL340623A1/xx unknown
- 1998-11-04 NZ NZ503890A patent/NZ503890A/xx unknown
- 1998-11-04 CN CN98810911A patent/CN1278732A/zh active Pending
- 1998-11-04 EE EEP200000211A patent/EE04092B1/xx not_active IP Right Cessation
- 1998-11-04 TR TR2000/01268T patent/TR200001268T2/xx unknown
- 1998-11-04 ES ES98956525T patent/ES2246541T3/es not_active Expired - Lifetime
- 1998-11-04 EA EA200000492A patent/EA200000492A1/ru unknown
- 1998-11-04 CZ CZ20001661A patent/CZ294155B6/cs not_active IP Right Cessation
- 1998-11-04 CA CA002307210A patent/CA2307210A1/en not_active Abandoned
- 1998-11-04 WO PCT/US1998/023427 patent/WO1999024027A2/en not_active Ceased
- 1998-11-04 JP JP2000520119A patent/JP2001522798A/ja not_active Ceased
- 1998-11-04 AU AU13031/99A patent/AU760540B2/en not_active Ceased
- 1998-11-04 HR HR20000269A patent/HRP20000269A2/hr not_active Application Discontinuation
- 1998-11-05 AR ARP980105591A patent/AR016667A1/es not_active Application Discontinuation
- 1998-11-05 ZA ZA9810136A patent/ZA9810136B/xx unknown
2000
- 2000-04-27 NO NO20002167A patent/NO20002167L/no not_active Application Discontinuation
- 2000-05-17 BG BG104451A patent/BG104451A/xx unknown
2003
- 2003-06-23 AU AU2003204896A patent/AU2003204896B2/en not_active Ceased

Also Published As

Publication number	Publication date
PL340623A1 (en)	2001-02-12
AU760540B2 (en)	2003-05-15
EP1051179A2 (en)	2000-11-15
NO20002167L (no)	2000-06-28
CA2307210A1 (en)	1999-05-20
ES2246541T3 (es)	2006-02-16
WO1999024027A2 (en)	1999-05-20
HUP0100293A3 (en)	2002-12-28
JP2001522798A (ja)	2001-11-20
DE69831605T2 (de)	2006-06-14
UA68365C2 (en)	2004-08-16
WO1999024027A3 (en)	1999-07-15
EA200000492A1 (ru)	2000-10-30
NZ503890A (en)	2002-08-28
DK1051179T3 (da)	2005-10-31
CZ294155B6 (cs)	2004-10-13
GEP20043290B (en)	2004-07-26
SK6482000A3 (en)	2000-11-07
ZA9810136B (en)	2000-05-05
EP1051179B1 (en)	2005-09-14
EE04092B1 (et)	2003-08-15
HUP0100293A2 (hu)	2001-10-28
BR9813982A (pt)	2000-09-26
ATE304359T1 (de)	2005-09-15
AU2003204896B2 (en)	2006-06-15
IL135621A0 (en)	2001-05-20
DE69831605D1 (de)	2005-10-20
TR200001268T2 (tr)	2001-01-22
EE200000211A (et)	2001-04-16
CZ20001661A3 (cs)	2000-12-13
HRP20000269A2 (en)	2000-12-31
NO20002167D0 (no)	2000-04-27
ID24568A (id)	2000-07-27
CN1278732A (zh)	2001-01-03
AR016667A1 (es)	2001-07-25
AU1303199A (en)	1999-05-31

Publication	Publication Date	Title
BG104451A (en)	2000-12-29	Antiestrogen and progestin-containing peroral contraceptives
NZ330741A (en)	2000-03-27	Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
AU560487B2 (en)	1987-04-09	Contraceptive comprising gestodene and ethinylestradiol
DE69118494D1 (de)	1996-05-09	Kontrazeptionsverfahren und Schema
AU645382B2 (en)	1994-01-13	Low estrogen oral contraceptives
FI922206A0 (fi)	1992-05-14	Osmotisk, oral doseringsform foer fertilitets kontroll.
DE69710896D1 (en)	2002-04-11	Progestogen-anti-progestogen therapien
LU90341I2 (fr)	1999-03-29	75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)
NZ333750A (en)	2000-09-29	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
ATE91410T1 (de)	1993-07-15	Osmotische dosierungsform.
MX9707009A (es)	1997-11-29	Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.
KR950024496U (ko)	1995-09-13	여성용 콘돔(女性用 condom)
NL1001243C1 (en)	1996-10-22	Contraceptive device for preventing pregnancy - comprises hose inserted in urinary passage of penis to trap ejaculated sperm